Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Ducommun

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
The EMBO Journal|November 11, 1991
cdc2 phosphorylation is required for its interaction with cyclinB Ducommun, P Brambilla, M A Félix, et al.
Infection and Immunity|December 11, 1997
Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activationC Comayras, C Tasca, S Y Pérès, et al.
Oncogene|May 24, 2000
Regulation of CDC25B phosphatases subcellular localizationN Davezac, V Baldin, B Gabrielli, et al.
FEBS Letters|August 5, 1996
Interaction studies between the p21Cip1/Waf1 cyclin-dependent kinase inhibitor and proliferating cell nuclear antigen (PCNA) by surface plasmon resonanceM Knibiehler, F Goubin, N Escalas, et al.
FEBS Letters|March 10, 2001
Study of the cytolethal distending toxin (CDT)-activated cell cycle checkpoint. Involvement of the CHK2 kinaseF Alby, R Mazars, J de Rycke, et al.
The Journal of Biological Chemistry|May 16, 2000
Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cellsJ M Darbon, M Penary, N Escalas, et al.
Oncogene|March 14, 2000
Specific interaction between 14-3-3 isoforms and the human CDC25B phosphataseV Mils, V Baldin, F Goubin, et al.
Oncogene|December 22, 1999
The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaksV Sert, C Cans, C Tasca, et al.
Experimental Cell Research|August 16, 2000
Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cellsL A Tintignac, M P Leibovitch, M Kitzmann, et al.
Oncogene|January 24, 2008
G2/M checkpoint stringency is a key parameter in the sensitivity of AML cells to genotoxic stressC Didier, C Cavelier, M Quaranta, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
The EMBO Journal|November 11, 1991
cdc2 phosphorylation is required for its interaction with cyclinB Ducommun, P Brambilla, M A Félix, et al.
Infection and Immunity|December 11, 1997
Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activationC Comayras, C Tasca, S Y Pérès, et al.
Oncogene|May 24, 2000
Regulation of CDC25B phosphatases subcellular localizationN Davezac, V Baldin, B Gabrielli, et al.
FEBS Letters|August 5, 1996
Interaction studies between the p21Cip1/Waf1 cyclin-dependent kinase inhibitor and proliferating cell nuclear antigen (PCNA) by surface plasmon resonanceM Knibiehler, F Goubin, N Escalas, et al.
FEBS Letters|March 10, 2001
Study of the cytolethal distending toxin (CDT)-activated cell cycle checkpoint. Involvement of the CHK2 kinaseF Alby, R Mazars, J de Rycke, et al.
The Journal of Biological Chemistry|May 16, 2000
Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cellsJ M Darbon, M Penary, N Escalas, et al.
Oncogene|March 14, 2000
Specific interaction between 14-3-3 isoforms and the human CDC25B phosphataseV Mils, V Baldin, F Goubin, et al.
Oncogene|December 22, 1999
The bacterial cytolethal distending toxin (CDT) triggers a G2 cell cycle checkpoint in mammalian cells without preliminary induction of DNA strand breaksV Sert, C Cans, C Tasca, et al.
Experimental Cell Research|August 16, 2000
Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cellsL A Tintignac, M P Leibovitch, M Kitzmann, et al.
Oncogene|January 24, 2008
G2/M checkpoint stringency is a key parameter in the sensitivity of AML cells to genotoxic stressC Didier, C Cavelier, M Quaranta, et al.
Pageof 6